申请人:Japan Tobacco Inc.
公开号:EP1452526A1
公开(公告)日:2004-09-01
An indole compound represented by the formula (1)
wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof or a prodrug thereof is useful as a therapeutic agents for diabetes having an HLGPa inhibitory activity.
由公式(1)表示的吲哚化合物,其中每个符号如规范中定义,其药用盐或其前药是作为具有HLGPa抑制活性的糖尿病治疗剂。